Correlation Between Processa Pharmaceuticals and Nascent Biotech

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Nascent Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Nascent Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and Nascent Biotech, you can compare the effects of market volatilities on Processa Pharmaceuticals and Nascent Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Nascent Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Nascent Biotech.

Diversification Opportunities for Processa Pharmaceuticals and Nascent Biotech

0.59

Correlation Coefficient

Processa Pharmaceuticals  Nascent Biotech

Very weak diversification

The 3 months correlation between Processa and Nascent is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Nascent Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nascent Biotech and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Nascent Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nascent Biotech has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Nascent Biotech go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Nascent Biotech

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to generate 0.35 times more return on investment than Nascent Biotech. However, Processa Pharmaceuticals is 2.83 times less risky than Nascent Biotech. It trades about -0.12 of its potential returns per unit of risk. Nascent Biotech is currently generating about -0.1 per unit of risk. If you would invest  141.00  in Processa Pharmaceuticals on October 21, 2024 and sell it today you would lose (60.00) from holding Processa Pharmaceuticals or give up 42.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	96.88%
Values	Daily Returns

Processa Pharmaceuticals  vs.  Nascent Biotech

Processa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Nascent Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nascent Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Processa Pharmaceuticals and Nascent Biotech

The main advantage of trading using opposite Processa Pharmaceuticals and Nascent Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Nascent Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nascent Biotech will offset losses from the drop in Nascent Biotech's long position.

The idea behind Processa Pharmaceuticals and Nascent Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.